This antiangiogenic action of IGFBP-6 was demonstrated in vivo in a tumor model by transplanting human Rh30 rhabdomyosarcoma cells stably transfected with IGFBP-6 into BALB/c nude mice (82). This evidence concerns the gene IGFBP6 and neoplasm.